CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
The Right Rx?
By Oliver Ryan, FORTUNE

(FORTUNE Magazine) - Will Internet prescription services ever be legit?

Peter Ax, former head of private equity at Lehman Brothers, certainly thinks so. In 2001 he purchased KwikMed, a legally troubled e-tailer of erectile-dysfunction drugs. After 14 months spent overhauling the company, he won a consent order from the state of Utah for the right to prescribe drugs online--a first in the U.S.

Pharma, heal thyself
Drug dealers were once favorite movie bad guys. These days, it's drug companies. Can they repair the damage? (Read the column)

The order has been fiercely opposed by Viagra maker Pfizer (Research) and the full complement of national medical associations. "Internet pseudo prescribing is the functional equivalent of pushing amphetamines at a truck stop," says Pfizer lawyer Arnold Friede. But KwikMed and its proponents say the company is a health-care innovator with the potential to drive down costs, and the legality of its business has been upheld by the Utah state legislature.

The debate--fueled by federal stings of rogue web pharmacies last year, which shut down 4,800 sites--will get its first dose of empirical evidence next month with the release of a study by Mark Munger, a dean in the College of Pharmacy at the University of Utah. Munger compared a sample of KwikMed patient records with data from a typical family clinic setting and, according to a sneak peak provided to FORTUNE, found that, at least for erectile-dysfunction medications, KwikMed's prescription process is just as safe. (Munger says he's taken no funds from KwikMed.)

KwikMed relies on an extensive online interview, the results of which are forwarded to a physician, who may approve or reject a prescription or follow up with further questions. The company argues that the approach makes sense for self-diagnosed conditions indicating relatively safe medications. "I don't believe we do away with all physical exams," says Ax. "What I do believe is that 20% to 50% of all physician visits are unnecessary." Ax hopes to expand KwikMed's offering to allergy and cholesterol drugs. Last year the company generated only $25 million in revenues, but monthly orders were up nearly 50%.

The Munger study is not likely to appease detractors. KwikMed is "not the 'standard practice of medicine,' " says James Rawson of the Federation of State Medical Boards, whose requirement of an initial visit to a doctor's office before any prescription is written carries enormous weight with regulators. When FORTUNE tested KwikMed's system with an order of Viagra, it was approved immediately. That was followed by a call from a KwikMed doctor, who canceled the order for us. But the next day, three blue pills arrived anyway. Apparently, there are still kinks in the system. Top of page

YOUR E-MAIL ALERTS
Follow the news that matters to you. Create your own alert to be notified on topics you're interested in.

Or, visit Popular Alerts for suggestions.
Manage alerts | What is this?
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.